218 related articles for article (PubMed ID: 14743742)
1. [Tumor markers in gynecological and breast cancer].
Jobo T; Sato R; Kuramoto H
Rinsho Byori; 2003 Dec; 51(12):1188-94. PubMed ID: 14743742
[TBL] [Abstract][Full Text] [Related]
2. The use of mucin-specific monoclonal antibodies and lectins in the detection of tumor-associated serum markers in gynecological cancer.
Devine PL; McGuckin MA; Ramm LE; Harada H; Ward BG
Cancer Biochem Biophys; 1993 Sep; 13(4):221-38. PubMed ID: 8521372
[TBL] [Abstract][Full Text] [Related]
3. Serous papillary adenocarcinoma of the female genital organs and invasive micropapillary carcinoma of the breast. Are WT1, CA125, and GCDFP-15 useful in differential diagnosis?
Moritani S; Ichihara S; Hasegawa M; Endo T; Oiwa M; Yoshikawa K; Sato Y; Aoyama H; Hayashi T; Kushima R
Hum Pathol; 2008 May; 39(5):666-71. PubMed ID: 18339419
[TBL] [Abstract][Full Text] [Related]
4. Clinical use of gynaecologic tumour markers.
Halila H; Alfthan H; Stenman UH
Ann Chir Gynaecol; 1989; 78(1):65-70. PubMed ID: 2547331
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic significance of tumor markers for gynecologic malignancies].
Aoki D; Hirasawa A; Susumu N
Gan To Kagaku Ryoho; 2005 Mar; 32(3):411-6. PubMed ID: 15791829
[TBL] [Abstract][Full Text] [Related]
6. [Tumor markers in gynecology. General review].
Briese V; Strache RR
Zentralbl Gynakol; 1988; 110(5):257-66. PubMed ID: 3287800
[TBL] [Abstract][Full Text] [Related]
7. Tumor markers for the diagnosis, prognosis, treatment and follow-up of gynaecological tumors.
Ulsperger E; Karrer K
Bull Soc Sci Med Grand Duche Luxemb; 1989; 126(1):33-43. PubMed ID: 2545372
[TBL] [Abstract][Full Text] [Related]
8. Circulating mucins as tumor markers in ovarian cancer (review).
Devine PL; McGuckin MA; Ward BG
Anticancer Res; 1992; 12(3):709-17. PubMed ID: 1622128
[TBL] [Abstract][Full Text] [Related]
9. A diagnostic evaluation of serum human telomerase reverse transcriptase mRNA as a novel tumor marker for gynecologic malignancies.
Miura N; Kanamori Y; Takahashi M; Sato R; Tsukamoto T; Takahashi S; Harada T; Sano A; Shomori K; Harada T; Kigawa J; Ito H; Terakawa N; Hasegawa J; Shiota G
Oncol Rep; 2007 Mar; 17(3):541-8. PubMed ID: 17273731
[TBL] [Abstract][Full Text] [Related]
10. Tumour markers in gynaecologic oncology.
Onsrud M
Scand J Clin Lab Invest Suppl; 1991; 206():60-70. PubMed ID: 1719611
[TBL] [Abstract][Full Text] [Related]
11. Combined measurement of serum sialyl Lewis X with serum CA15-3 in breast cancer patients.
Kurebayashi J; Nomura T; Hirono M; Okubo S; Udagawa K; Shiiki S; Ikeda M; Nakashima K; Tanaka K; Sonoo H
Jpn J Clin Oncol; 2006 Mar; 36(3):150-3. PubMed ID: 16520359
[TBL] [Abstract][Full Text] [Related]
12. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia.
Cole LA; Butler SA; Khanlian SA; Giddings A; Muller CY; Seckl MJ; Kohorn EI
Gynecol Oncol; 2006 Aug; 102(2):151-9. PubMed ID: 16631241
[TBL] [Abstract][Full Text] [Related]
13. Serum tumor markers.
Perkins GL; Slater ED; Sanders GK; Prichard JG
Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
[TBL] [Abstract][Full Text] [Related]
14. [Clinical value of combined detection of serum tumor markers in lung cancer diagnosis].
Chen F; Li WM; Wang DM; Gao SS; Bao Y; Chen WB; Liu D
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):832-5. PubMed ID: 19024326
[TBL] [Abstract][Full Text] [Related]
15. Knowledge of tumor markers and the psychological consequences of tumor marker sampling in patients with gynecologic cancers.
Mayerhofer K; Bodner K; Aktas C; Schindl M; Kaider A; Leodolter S; Joura EA; Kainz C
Anticancer Res; 2000; 20(2B):1281-4. PubMed ID: 10810435
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis: tumor marker].
Inaba N; Takamizawa Y; Ota J; Fukazawa K
Gan No Rinsho; 1990 Aug; 36(10):1123-7. PubMed ID: 2214148
[TBL] [Abstract][Full Text] [Related]
17. Midkine in plasma as a novel breast cancer marker.
Ibusuki M; Fujimori H; Yamamoto Y; Ota K; Ueda M; Shinriki S; Taketomi M; Sakuma S; Shinohara M; Iwase H; Ando Y
Cancer Sci; 2009 Sep; 100(9):1735-9. PubMed ID: 19538527
[TBL] [Abstract][Full Text] [Related]
18. [Tumor marker--screening for gynecological cancer; personal experience. Utility of tumor markers in screening of ovarian cancer].
Kimura E; Kobayashi S; Terashima Y
Gan To Kagaku Ryoho; 1990 Dec; 17(12):2443-50. PubMed ID: 2260879
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of different serum tumor markers in gynecological malignancies.
Paulick R; Caffier H; Horner G; Lang K; Filbry E
Cancer Detect Prev; 1985; 8(1-2):115-20. PubMed ID: 4064031
[TBL] [Abstract][Full Text] [Related]
20. [MSA--a new sensitive tumor marker in breast carcinoma].
Zahm DM; Greinke C; Nöschel H
Zentralbl Gynakol; 1996; 118(12):659-64. PubMed ID: 9082702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]